Topical scar treatment market in China and Southeast Asia worth $ 1,451.1 million by 2030, reveals P&S Intelligence

NEW YORK, May 18, 2021 / PRNewswire / – Almost 900 million people suffer from skin diseases at any given time, according to the World Health Organization (WHO). Among the most common are pyoderma, acne, scabies, eczema, and warts. With the increasing prevalence of these problems, the China and South East Asia topical scar treatment market will grow from $ 701.6 million in 2020 at $ 1,451.1 million in 2030, at a CAGR of 7.7% between 2021 and 2030.

For example, in Thailand, 110,205 people had skin disease, including dermatitis, hives and bacterial skin diseases, in 2018, according to an article in the BMC Public Health. The reason this factor is driving the topical scar treatment market by China and SEA is that many of these diseases either manifest themselves or leave scars after they are healed. Plus, topical treatments are convenient to administer, painless, non-invasive, and cost-effective.

Main conclusions of China and the SEA topical scar treatment market

  • A booming geriatric population, a major growth engine for the industry
  • Creams are the most popular scar treatment products in SEA and China
  • Pharmacies represent the highest product sales
  • Demand for silicone products is growing rapidly
  • Growing e-commerce penetration offering growth opportunities
  • China largest market for topical scar treatment products in SEA

Get a sample copy of this report at @ https://www.psmarketresearch.com/market-analysis/topical-scar-treatment-market/report-sample

Due to the COVID-19 pandemic, the China and the SEA topical scar treatment market has been negatively impacted due to lockdowns and social distancing measures implemented in the region. This has dramatically reduced the incidence of post-surgical scarring, sports injuries, burns, and traffic accidents, which has had a direct negative impact on the demand for topical scar treatment products.

The creams category will grow fastest China and the SEA topical scar treatment market in the coming years, depending on the type of product. Creams have been shown to be effective in bleaching, smoothing, flattening, and reducing the appearance of existing scars and preventing new scars from forming on the skin.

In the past, the China and the SEA topical scar treatment market was dominated by atrophic and acne scar category, under segmentation by scar type. Over 90% of teens in the region suffer from acne due to hormonal changes and a fatty diet, which is why they are generating a high demand for topical products for the treatment of acne and atrophic scars.

Explore the Detailed Report with Impact Analysis COVID-19 on Topical Scar Treatment Market in China, South Korea, Taiwan, Hong Kong, and South East Asia – Estimate and forecast of revenues by 2030 @ https://www.psmarketresearch.com/market-analysis/topical-scar-treatment-market

The pharmacy category is expected to continue to hold the largest share of the China and the SEA topical scar treatment market during this decade, in the distribution channel segment. Most scar treatment products are purchased with a doctor’s prescription, which is why pharmacies continue to account for their highest sales.

Until now, China has been the largest contributor to the SEA topical scar treatment market, and it will also experience the fastest growth in the years to come. The growing geriatric population, the incidence of dermatological diseases and the economic growth rate are driving the demand for these products in the country, as are the technological advancements in the field.

Learn more about this report at @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=topical-scar-treatment-market

Topical Scars Topical Treatment Market Companies China and SEA are Perrigo Company plc, Cicatricure (Genomma Lab United States Inc.), Laboratoire HRA Pharma SAS, Terez & Honor, Aroamas LLC (EHY HOLDINGS LLC), Sientra Inc., Integra LifeSciences Holdings Corporation, Revitol Corporation, Johnson & Johnson, Sonoma Pharmaceuticals Inc., Mölnlycke Health Care AB, Smith & Nephew PLC, Mylan NV, Alliance Pharma plc and Merz Pharma GmbH & Co. KGaA.

Browse other related reports:

Dermatological Drugs Market Report – Geographically, Asia Pacific The dermatological drugs market is expected to register the highest CAGR during the forecast period. This may be due to the increase in disposable income, the increasing prevalence of skin diseases and the rise in health expenditure in countries in the region.

Scar Treatment Market Report – Geographically, the scar treatment market is expected to show the strongest growth North America in the near future. The second strongest market growth will be observed in Europe In the coming years.

About P&S intelligence

P&S Intelligence is a provider of market research and consulting services addressing the market information needs of growing industries around the world. As an enterprising research and consultancy firm, P&S, as a research and consultancy firm, believes in providing in-depth landscape analyzes on the ever-changing market scenario, to enable companies to make decisions. informed and to base their business strategies with astuteness.

Contact:

Prajneesh Kumar
P&S intelligence
Contact: + 1-347-960-6455
E-mail: [email protected]
The Web: https://www.psmarketresearch.com

SOURCE P&S Intelligence


Source link

About Sally Dominguez

Check Also

4 magical benefits of green tea for your face

As wellness trends come and go, green tea is a classic as people have used …

Leave a Reply

Your email address will not be published. Required fields are marked *